CSB Bancorp, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
CSBBStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| September 30, | December 31, | |
|---|---|---|
| (Dollars in thousands, except per share data) | 2025 | 2024 |
| ASSETS | ||
| Cash and cash equivalents | ||
| Cash and due from banks | $20,069 | $21,287 |
| Interest-earning deposits in other banks | 60,408 | 52,222 |
| Federal funds sold | 330 | — |
| Total cash and cash equivalents | 80,807 | 73,509 |
| Securities | ||
| Available-for-sale, at fair value | 115,795 | 125,434 |
| Held-to-maturity; fair value of $166,654 in 2025 and $172,603 in 2024 ($0 credit loss allowance for 2025 and 2024) | 190,027 | 204,309 |
| Equity securities | 269 | 266 |
| Restricted stock, at cost | 1,520 | 1,520 |
| Total securities | 307,611 | 331,529 |
| Loans held for sale | 384 | 283 |
| Loans | 810,048 | 737,641 |
| Less allowance for credit losses | 8,720 | 7,595 |
| Net loans | 801,328 | 730,046 |
| Premises and equipment, net | 13,716 | 14,069 |
| Bank-owned life insurance | 30,899 | 28,225 |
| Goodwill | 4,728 | 4,728 |
| Accrued interest receivable and other assets | 8,884 | 9,111 |
| TOTAL ASSETS | $1,248,357 | $1,191,500 |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||
| LIABILITIES | ||
| Deposits | ||
| Noninterest-bearing | $277,838 | $281,358 |
| Interest-bearing | 818,758 | 763,529 |
| Total deposits | 1,096,596 | 1,044,887 |
| Short-term borrowings | 20,304 | 25,683 |
| Other borrowings | 941 | 1,266 |
| Allowance for credit losses on off-balance sheet commitments | 514 | 524 |
| Accrued interest payable and other liabilities | 4,812 | 4,305 |
| TOTAL LIABILITIES | 1,123,167 | 1,076,665 |
| SHAREHOLDERS' EQUITY | ||
| Common stock, $6.25 par value. Authorized 9,000,000 shares; issued 2,980,602 shares; outstanding 2,632,498 shares in 2025 and 2,650,089 in 2024 | 18,629 | 18,629 |
| Additional paid-in capital | 9,815 | 9,815 |
| Retained earnings | 111,380 | 103,105 |
| Treasury stock at cost: 348,104 shares in 2025 and 330,513 shares in 2024 | (9,020) | (8,294) |
| Accumulated other comprehensive loss | (5,614) | (8,420) |
| TOTAL SHAREHOLDERS' EQUITY | 125,190 | 114,835 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $1,248,357 | $1,191,500 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.